Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

  • Filters activated: Field: Title Word. Clear all
1.

A genetic roadmap of pancreatic cancer: still evolving.

Notta F, Hahn SA, Real FX.

Gut. 2017 Dec;66(12):2170-2178. doi: 10.1136/gutjnl-2016-313317. Epub 2017 Oct 9. Review.

PMID:
28993418
2.

Circular RNA expression in cutaneous squamous cell carcinoma.

Sand M, Bechara FG, Gambichler T, Sand D, Bromba M, Hahn SA, Stockfleth E, Hessam S.

J Dermatol Sci. 2016 Sep;83(3):210-8. doi: 10.1016/j.jdermsci.2016.05.012. Epub 2016 May 25.

PMID:
27298156
3.

Circular RNA expression in basal cell carcinoma.

Sand M, Bechara FG, Sand D, Gambichler T, Hahn SA, Bromba M, Stockfleth E, Hessam S.

Epigenomics. 2016 May;8(5):619-32. doi: 10.2217/epi-2015-0019. Epub 2016 Apr 20.

PMID:
27097056
4.

Expression profiles of long noncoding RNAs in cutaneous squamous cell carcinoma.

Sand M, Bechara FG, Sand D, Gambichler T, Hahn SA, Bromba M, Stockfleth E, Hessam S.

Epigenomics. 2016 Apr;8(4):501-18. doi: 10.2217/epi-2015-0012. Epub 2016 Apr 12.

PMID:
27067026
5.

Long-noncoding RNAs in basal cell carcinoma.

Sand M, Bechara FG, Sand D, Gambichler T, Hahn SA, Bromba M, Stockfleth E, Hessam S.

Tumour Biol. 2016 Aug;37(8):10595-608. doi: 10.1007/s13277-016-4927-z. Epub 2016 Feb 9.

PMID:
26861560
6.

Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.

Mazur PK, Herner A, Mello SS, Wirth M, Hausmann S, Sánchez-Rivera FJ, Lofgren SM, Kuschma T, Hahn SA, Vangala D, Trajkovic-Arsic M, Gupta A, Heid I, Noël PB, Braren R, Erkan M, Kleeff J, Sipos B, Sayles LC, Heikenwalder M, Heßmann E, Ellenrieder V, Esposito I, Jacks T, Bradner JE, Khatri P, Sweet-Cordero EA, Attardi LD, Schmid RM, Schneider G, Sage J, Siveke JT.

Nat Med. 2015 Oct;21(10):1163-71. doi: 10.1038/nm.3952. Epub 2015 Sep 21.

7.

A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling.

Kong B, Wu W, Cheng T, Schlitter AM, Qian C, Bruns P, Jian Z, Jäger C, Regel I, Raulefs S, Behler N, Irmler M, Beckers J, Friess H, Erkan M, Siveke JT, Tannapfel A, Hahn SA, Theis FJ, Esposito I, Kleeff J, Michalski CW.

Gut. 2016 Apr;65(4):647-57. doi: 10.1136/gutjnl-2014-307616. Epub 2015 Jan 19.

PMID:
25601637
8.

New insights in the composition of extracellular vesicles from pancreatic cancer cells: implications for biomarkers and functions.

Klein-Scory S, Tehrani MM, Eilert-Micus C, Adamczyk KA, Wojtalewicz N, Schnölzer M, Hahn SA, Schmiegel W, Schwarte-Waldhoff I.

Proteome Sci. 2014 Nov 18;12(1):50. doi: 10.1186/s12953-014-0050-5. eCollection 2014.

9.

Induction of pancreatic cancer cell migration by an autocrine epidermal growth factor receptor activation.

Stock AM, Hahn SA, Troost G, Niggemann B, Zänker KS, Entschladen F.

Exp Cell Res. 2014 Aug 15;326(2):307-14. doi: 10.1016/j.yexcr.2014.04.022. Epub 2014 May 5.

PMID:
24810090
10.

A microRNA-based test improves endoscopic ultrasound-guided cytologic diagnosis of pancreatic cancer.

Brand RE, Adai AT, Centeno BA, Lee LS, Rateb G, Vignesh S, Menard C, Wiechowska-Kozłowska A, Bołdys H, Hartleb M, Sanders MK, Munding JB, Tannapfel A, Hahn SA, Stefańczyk L, Tsongalis GJ, Whitcomb DC, Conwell DL, Morisset JA, Gardner TB, Gordon SR, Suriawinata AA, Lloyd MB, Wylie D, Labourier E, Andruss BF, Szafranska-Schwarzbach AE.

Clin Gastroenterol Hepatol. 2014 Oct;12(10):1717-23. doi: 10.1016/j.cgh.2014.02.038. Epub 2014 Mar 21.

PMID:
24662333
11.

Analysis of U2 small nuclear RNA fragments in the bile differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders.

Baraniskin A, Nöpel-Dünnebacke S, Schumacher B, Gerges C, Bracht T, Sitek B, Meyer HE, Gerken G, Dechene A, Schlaak JF, Schroers R, Pox C, Schmiegel W, Hahn SA.

Dig Dis Sci. 2014 Jul;59(7):1436-41. doi: 10.1007/s10620-014-3034-5. Epub 2014 Jan 31.

PMID:
24482036
12.

Circulating U2 small nuclear RNA fragments as a novel diagnostic tool for patients with epithelial ovarian cancer.

Kuhlmann JD, Baraniskin A, Hahn SA, Mosel F, Bredemeier M, Wimberger P, Kimmig R, Kasimir-Bauer S.

Clin Chem. 2014 Jan;60(1):206-13. doi: 10.1373/clinchem.2013.213066. Epub 2013 Nov 8.

13.

Lentiviral overexpression of miRNAs.

Zöllner H, Hahn SA, Maghnouj A.

Methods Mol Biol. 2014;1095:177-90. doi: 10.1007/978-1-62703-703-7_15.

PMID:
24166313
14.

Quantitative RT-PCR specific for precursor and mature miRNAs.

Zöllner H, Hahn SA, Maghnouj A.

Methods Mol Biol. 2014;1095:121-34. doi: 10.1007/978-1-62703-703-7_10.

PMID:
24166308
15.

The pancreatic expression database: recent extensions and updates.

Dayem Ullah AZ, Cutts RJ, Ghetia M, Gadaleta E, Hahn SA, Crnogorac-Jurcevic T, Lemoine NR, Chelala C.

Nucleic Acids Res. 2014 Jan;42(Database issue):D944-9. doi: 10.1093/nar/gkt959. Epub 2013 Oct 25.

16.

Keratin23 (KRT23) knockdown decreases proliferation and affects the DNA damage response of colon cancer cells.

Birkenkamp-Demtröder K, Hahn SA, Mansilla F, Thorsen K, Maghnouj A, Christensen R, Øster B, Ørntoft TF.

PLoS One. 2013 Sep 9;8(9):e73593. doi: 10.1371/journal.pone.0073593. eCollection 2013.

17.

Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Tissue Xenografts.

Hermann PC, Trabulo SM, Sainz B Jr, Balic A, Garcia E, Hahn SA, Vandana M, Sahoo SK, Tunici P, Bakker A, Hidalgo M, Heeschen C.

PLoS One. 2013 Jun 18;8(6):e66371. doi: 10.1371/journal.pone.0066371. Print 2013.

18.

Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling.

Zimmermann G, Papke B, Ismail S, Vartak N, Chandra A, Hoffmann M, Hahn SA, Triola G, Wittinghofer A, Bastiaens PI, Waldmann H.

Nature. 2013 May 30;497(7451):638-42. doi: 10.1038/nature12205. Epub 2013 May 22.

PMID:
23698361
19.

Norepinephrine inhibits the migratory activity of pancreatic cancer cells.

Stock AM, Powe DG, Hahn SA, Troost G, Niggemann B, Zänker KS, Entschladen F.

Exp Cell Res. 2013 Jul 15;319(12):1744-58. doi: 10.1016/j.yexcr.2013.04.015. Epub 2013 Apr 29.

PMID:
23639786
20.

Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.

Sand M, Skrygan M, Sand D, Georgas D, Gambichler T, Hahn SA, Altmeyer P, Bechara FG.

Cell Tissue Res. 2013 Jan;351(1):85-98. doi: 10.1007/s00441-012-1514-5. Epub 2012 Oct 31.

PMID:
23111773

Supplemental Content

Loading ...
Support Center